Literature DB >> 30168534

The hepatocellular carcinoma market.

Joshua Dawkins1, Rachel M Webster1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30168534     DOI: 10.1038/nrd.2018.146

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  23 in total

Review 1.  Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Hepatocellular Carcinoma: A New Update.

Authors:  Maher Hendi; Yiping Mou; Jiemin Lv; Bin Zhang; Xiujun Cai
Journal:  Gastrointest Tumors       Date:  2021-07-15

2.  CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma.

Authors:  Xiaoliang Liang; Fei Song; Wanzhi Fang; Yu Zhang; Zihan Feng; Zeyin Chen; Lu Han; Zhong Chen
Journal:  Int J Gen Med       Date:  2022-06-16

Review 3.  MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.

Authors:  Ulrich H Weidle; Daniela Schmid; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

4.  Development and Validation of a RNA Binding Protein-Associated Prognostic Model for Hepatocellular Carcinoma.

Authors:  Ming Wang; Feng Jiang; Ke Wei; Jimei Wang; Guoping Zhou; Chuyan Wu; Guoyong Yin
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 5.  Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets.

Authors:  Xiang-Yuan Luo; Kong-Ming Wu; Xing-Xing He
Journal:  J Exp Clin Cancer Res       Date:  2021-05-18

6.  Intratumoral Microbiome of Human Primary Liver Cancer.

Authors:  Dingding Qu; Yi Wang; Qingxin Xia; Jing Chang; Xiangnan Jiang; He Zhang
Journal:  Hepatol Commun       Date:  2022-02-22

Review 7.  Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment.

Authors:  Li-Wei Qiu; Yi-Fei Liu; Xiao-Qing Cao; Yan Wang; Xiao-Hong Cui; Xian Ye; Shuo-Wen Huang; Hong-Jun Xie; Hai-Jian Zhang
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

8.  A hint from zebrafish models of hepatic tumorigenesis: Targeting stearoyl-CoA desaturase.

Authors:  Kunpeng Lv; Fei Fei; Xu Wang
Journal:  Oncotarget       Date:  2019-01-29

9.  Expression of La Ribonucleoprotein Domain Family Member 4B (LARP4B) in Liver Cancer and Their Clinical and Prognostic Significance.

Authors:  Yanqing Li; Yan Jiao; Yang Li; Yanan Liu
Journal:  Dis Markers       Date:  2019-10-22       Impact factor: 3.434

10.  Dynamic Collaborations for the Development of Immune Checkpoint Blockade Agents.

Authors:  Arisa Djurian; Tomohiro Makino; Yeongjoo Lim; Shintaro Sengoku; Kota Kodama
Journal:  J Pers Med       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.